Suhas Subramanyam Questions 23andMe's Data Deletion Process Amidst Bankruptcy

Concerns Over 23andMe Data Deletion Process

• 💡 Suhas Subramanyam raised concerns during a House Oversight Committee hearing regarding the data deletion process for 23andMe users.
• 📌 Many users who signed up years ago, often for free kits, are worried about the current status and control of their genetic data.
• 🔍 Subramanyam noted that information about 23andMe's bankruptcy proceedings is not prominently displayed on their website, requiring users to dig deep to find it.
• ⚠️ Instructions for deleting data are also described as buried and not readily apparent, making it difficult for users to feel in control.

Data Sale and Third-Party Access

• ❓ A key question raised is whether companies acquiring 23andMe's assets in bankruptcy can sell the data to other companies.
• 📄 The potential acquirers are adopting 23andMe's privacy policies, which Subramanyam interprets as allowing for the sale of assets, including data.
• 📈 This raises concerns that genetic data could end up with multiple companies, potentially leading to its widespread distribution.

Risks of Genetic Data Exposure

• 🏥 If a healthcare company acquires the data, there's a risk they could use genetic information to raise insurance premiums based on predispositions.
• 🔒 The sensitive nature of genetic data means it could be open to abuse beyond insurance, potentially impacting other aspects of individuals' lives.
• 🌍 There's also a significant concern that foreign actors could acquire or hack this data, posing a national security threat.
• ⚠️ The transcript references a past breach where a hacker posted DNA data, including that of Chinese and Jewish ancestry, on the dark web.